The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation (original) (raw)

• Wilkinson, K. D. The discovery of ubiquitin-dependent proteolysis. Proc. Natl Acad. Sci. USA 102, 15280–15282 (2005).
  CAS PubMed PubMed Central Google Scholar
• Shabek, N., Iwai, K. & Ciechanover, A. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target. Biochem. Biophys. Res. Commun. 363, 425–431 (2007).
  CAS PubMed Google Scholar
• Hershko, A., Eytan, E., Ciechanover, A. & Haas, A. L. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins. J. Biol. Chem. 257, 13964–13970 (1982). The first description of the role of the ubiquitin proteolytic system in the degradation of proteins in intact nucleated cells. All prior studies describing the roles of the system were carried out using reticulocytes and mostly cell-free extracts from these cells, which are terminally differentiating red blood cells.
  CAS PubMed Google Scholar
• Haas, A. L. & Bright, P. M. The dynamics of ubiquitin pools within cultured human lung fibroblasts. J. Biol. Chem. 262, 345–351 (1987).
  CAS PubMed Google Scholar
• Patel, M. B. & Majetschak, M. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol. Res. 56, 341–350 (2007).
  CAS PubMed Google Scholar
• Ciechanover, A., Elias, S., Heller, H., Ferber, S. & Hershko, A. Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes. J. Biol. Chem. 255, 7525–7528 (1980). The first detailed characterization of ubiquitin.
  CAS PubMed Google Scholar
• Vijay-Kumar, S., Bugg, C. E. & Cook, W. J. Structure of ubiquitin refined at 1.8 Å resolution. J. Mol. Biol. 194, 531–544 (1987). Detailed three-dimensional structure of ubiquitin.
  CAS PubMed Google Scholar
• Carlson, N. & Rechsteiner, M. Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J. Cell Biol. 104, 537–546 (1987).
  CAS PubMed Google Scholar
• Hiroi, Y. & Rechsteiner, M. Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett. 307, 156–161 (1992).
  CAS PubMed Google Scholar
• Leggett, D. S. et al. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 10, 495–507 (2002). Describes Ubp6 as a proteasome-associated DUB and details its role in controlling cellular ubiquitin levels and proteasomal degradation by balancing the deubiquitylating and proteolytic activities of the protease.
  CAS PubMed Google Scholar
• Shabek, N., Herman-Bachinsky, Y. & Ciechanover, A. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc. Natl Acad. Sci. USA 106, 11907–11912 (2009). Description of degradation of ubiquitin as a monomer, as a C-terminally extended molecule and as part of the substrate-anchored polyubiquitin chain.
  CAS PubMed PubMed Central Google Scholar
• Verhoef, L. G. et al. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates. FASEB J. 23, 123–133 (2009). Describes the C-terminal extension tail as a ubiquitin-destabilizing element.
  CAS PubMed Google Scholar
• Piotrowski, J. et al. Inhibition of the 26S proteasome by polyubiquitin chains synthesized to have defined lengths. J. Biol. Chem. 272, 23712–23721 (1997).
  CAS PubMed Google Scholar
• Park, Y., Yoon, S. K. & Yoon, J. B. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway. J. Biol. Chem. 284, 1540–1549 (2009).
  CAS PubMed Google Scholar
• Xia, Z. P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114–119 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kimura, Y. et al. An inhibitor of a deubiquitinating enzyme regulates ubiquitin homeostasis. Cell 137, 549–559 (2009).
  CAS PubMed Google Scholar
• Anderson, C. et al. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95, 724–731 (2005).
  CAS PubMed Google Scholar
• Hanna, J., Leggett, D. S. & Finley, D. Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol. Cell. Biol. 23, 9251–9261 (2003).
  CAS PubMed PubMed Central Google Scholar
• Verma, R. et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298, 611–615 (2002).
  CAS PubMed Google Scholar
• Lee, M. J., Lee, B. H., Hanna, J., King, R. W. & Finley, D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell Proteomics 10, R110.003871 (2011).
  PubMed Google Scholar
• Hanna, J., Meides, A., Zhang, D. P. & Finley, D. A ubiquitin stress response induces altered proteasome composition. Cell 129, 747–759 (2007). Demonstrates that ubiquitin stress induces Ubp6, which rescues ubiquitin from target substrates, thus helping to restore ubiquitin homeostasis.
  CAS PubMed Google Scholar
• Hanna, J. et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127, 99–111 (2006).
  CAS PubMed Google Scholar
• Peth, A., Uchiki, T. & Goldberg, A. L. ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. Mol. Cell 40, 671–681 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kumar, K. S., Spasser, L., Ohayon, S., Erlich, L. A. & Brik, A. Expeditious chemical synthesis of ubiquitinated peptides employing orthogonal protection and native chemical ligation. Bioconjug. Chem. 22, 137–143 (2011). Describes a novel synthetic method to generate peptides and proteins to which ubiquitin is attached by an isopeptide bond to a Lys residue that can be inserted at any point of choice along the chain.
  CAS PubMed Google Scholar
• Ciechanover, A. & Ben-Saadon, R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14, 103–106 (2004).
  CAS PubMed Google Scholar
• Papa, F. R. & Hochstrasser, M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366, 313–319 (1993).
  CAS PubMed Google Scholar
• Dupre, S. & Haguenauer-Tsapis, R. Deubiquitination step in the endocytic pathway of yeast plasma membrane proteins: crucial role of Doa4p ubiquitin isopeptidase. Mol. Cell. Biol. 21, 4482–4494 (2001).
  CAS PubMed PubMed Central Google Scholar
• Prakash, S., Inobe, T., Hatch, A. J. & Matouschek, A. Substrate selection by the proteasome during degradation of protein complexes. Nature Chem. Biol. 5, 29–36 (2009). Establishes that two elements are critical for the proteasome to recognize and degrade a target substrate — conjugated ubiquitin and an unstructured tail in the substrate that will allow its entry into the 20S CP.
  CAS Google Scholar
• van Leeuwen, F. W., Hol, E. M. & Fischer, D. F. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system. J. Alzheimers Dis. 9, 319–325 (2006). Describes the naturally occurring C-terminally extended ubiquitin UBB +1 , which inhibits the proteasome as it binds to it but, owing to its tail, which is too short (19 residues), cannot be degraded.
  CAS PubMed Google Scholar
• Lam, Y. A. et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 9902–9906 (2000).
  CAS PubMed PubMed Central Google Scholar
• Lorick, K. L. et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA 96, 11364–11369 (1999). Establishes that RING finger proteins are generally E3s and that they can mediate self-ubiquitylation in vitro.
  CAS PubMed PubMed Central Google Scholar
• Ravid, T. & Hochstrasser, M. Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nature Cell Biol. 9, 422–427 (2007).
  CAS PubMed Google Scholar
• Dikic, I., Wakatsuki, S. & Walters, K. J. Ubiquitin-binding domains — from structures to functions. Nature Rev. Mol. Cell Biol. 10, 659–671 (2009).
  CAS Google Scholar
• Wade, M., Wang, Y. V. & Wahl, G. M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299–309 (2010).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. T. & Gu, W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86–92 (2010).
  CAS PubMed Google Scholar
• Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945–8951 (2000).
  CAS PubMed Google Scholar
• Honda, R. & Yasuda, H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473–1476 (2000). References 36 and 37 establish that MDM2 can target itself for ubiquitylation through its RING finger.
  CAS PubMed Google Scholar
• Linke, K. et al. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15, 841–848 (2008).
  CAS PubMed Google Scholar
• Tanimura, S. et al. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447, 5–9 (1999).
  CAS PubMed Google Scholar
• Linares, L. K., Hengstermann, A., Ciechanover, A., Muller, S. & Scheffner, M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl Acad. Sci. USA 100, 12009–12014 (2003).
  CAS PubMed PubMed Central Google Scholar
• Okamoto, K., Taya, Y. & Nakagama, H. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett. 583, 2710–2714 (2009).
  CAS PubMed Google Scholar
• Stad, R. et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2, 1029–1034 (2001).
  CAS PubMed PubMed Central Google Scholar
• Cummins, J. M. & Vogelstein, B. HAUSP is required for p53 destabilization. Cell Cycle 3, 689–692 (2004).
  CAS PubMed Google Scholar
• Li, M., Brooks, C. L., Kon, N. & Gu, W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879–886 (2004).
  CAS PubMed Google Scholar
• Meulmeester, E., Pereg, Y., Shiloh, Y. & Jochemsen, A. G. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166–1170 (2005).
  CAS PubMed Google Scholar
• Meulmeester, E. et al. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18, 565–576 (2005). References 43, 44, 45, 46 establish the deubiquitylation of MDM2 and MDMX by the DUB USP7 and the significance of regulation of this association in response to genotoxic stress.
  CAS PubMed Google Scholar
• Acconcia, F., Sigismund, S. & Polo, S. Ubiquitin in trafficking: the network at work. Exp. Cell Res. 315, 1610–1618 (2009).
  CAS PubMed Google Scholar
• Rotin, D. & Kumar, S. Physiological functions of the HECT family of ubiquitin ligases. Nature Rev. Mol. Cell Biol. 10, 398–409 (2009).
  CAS Google Scholar
• Macias, M. J., Wiesner, S. & Sudol, M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513, 30–37 (2002).
  CAS PubMed Google Scholar
• Ryan, P. E., Davies, G. C., Nau, M. M. & Lipkowitz, S. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci. 31, 79–88 (2006).
  CAS PubMed Google Scholar
• Kales, S. C., Ryan, P. E., Nau, M. M. & Lipkowitz, S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 70, 4789–4794 (2010).
  CAS PubMed PubMed Central Google Scholar
• Davies, G. C. et al. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23, 7104–7115 (2004).
  CAS PubMed Google Scholar
• Ettenberg, S. A. et al. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 276, 27677–27684 (2001).
  CAS PubMed Google Scholar
• Magnifico, A. et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169–43177 (2003). References 53 and 54 , respectively, establish the RTK-mediated down regulation of CBL proteins by self-ubiquitylation and their ubiquitylation by NEDD4 family members. Reference 54 is the first clear example of the targeting of one E3 family by another.
  CAS PubMed Google Scholar
• Yang, B. et al. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nature Immunol. 9, 1356–1363 (2008).
  CAS Google Scholar
• Gay, D. L., Ramon, H. & Oliver, P. M. Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity. Immunol. Res. 42, 51–64 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gallagher, E., Gao, M., Liu, Y. C. & Karin, M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl Acad. Sci. USA 103, 1717–1722 (2006).
  CAS PubMed PubMed Central Google Scholar
• Azakir, B. A. & Angers, A. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling. Cell. Signal. 21, 1326–1336 (2009).
  CAS PubMed Google Scholar
• Mouchantaf, R. et al. The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. J. Biol. Chem. 281, 38738–38747 (2006).
  CAS PubMed Google Scholar
• Tsai, Y. C. & Weissman, A. M. The unfolded protein response, degradation from endoplasmic reticulum and cancer. Genes Cancer 1, 764–778 (2010).
  CAS PubMed PubMed Central Google Scholar
• Fang, S. et al. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 98, 14422–14427 (2001).
  CAS PubMed PubMed Central Google Scholar
• Tsai, Y. C. et al. The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nature Med. 13, 1504–1509 (2007).
  CAS PubMed Google Scholar
• Morito, D. et al. Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRδF508. Mol. Biol. Cell 19, 1328–1336 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ye, Y. et al. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl Acad. Sci. USA 102, 14132–14138 (2005).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. N., Song, B., DeBose-Boyd, R. A. & Ye, J. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281, 39308–39315 (2006).
  CAS PubMed Google Scholar
• Chen, B. et al. The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc. Natl Acad. Sci. USA 103, 341–346 (2006).
  CAS PubMed PubMed Central Google Scholar
• Das, R. et al. Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol. Cell 34, 674–685 (2009).
  CAS PubMed PubMed Central Google Scholar
• Shmueli, A., Tsai, Y. C., Yang, M., Braun, M. A. & Weissman, A. M. Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 390, 758–762 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ballar, P., Ors, A. U., Yang, H. & Fang, S. Differential regulation of CFTRΔF508 degradation by ubiquitin ligases gp78 and Hrd1. Int. J. Biochem. Cell Biol. 42, 167–173 (2010). Reference 68 and 69 describe the regulation of the pro-metastatic ERAD E3 gp78 by HRD1.
  CAS PubMed Google Scholar
• Gardner, R. G. et al. Endoplasmic reticulum degradation requires lumen to cytosol signaling. Transmembrane control of Hrd1p by Hrd3p. J. Cell Biol. 151, 69–82 (2000).
  CAS PubMed PubMed Central Google Scholar
• Iida, Y. et al. SEL1L protein critically determines the stability of the HRD1-SEL1L endoplasmic reticulum-associated degradation (ERAD) complex to optimize the degradation kinetics of ERAD substrates. J. Biol. Chem. 286, 16929–16939 (2011).
  CAS PubMed PubMed Central Google Scholar
• Carroll, S. M. & Hampton, R. Y. Usa1p is required for optimal function and regulation of the Hrd1p endoplasmic reticulum-associated degradation ubiquitin ligase. J. Biol. Chem. 285, 5146–5156 (2010). Shows that the critical yeast ERAD E3 Hrd1 undergoes self-ubiquitylation in trans in a manner that is regulated by a relative lack of Hrd3 and the presence of Usa1, both of which are components of the Hrd1 ubiquitin ligase complex.
  CAS PubMed Google Scholar
• Horn, S. C. et al. Usa1 functions as a scaffold of the HRD-ubiquitin ligase. Mol. Cell 36, 782–793 (2009).
  CAS PubMed Google Scholar
• Cao, R. et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298, 1039–1043 (2002).
  CAS PubMed Google Scholar
• Ben-Saadon, R., Zaaroor, D., Ziv, T. & Ciechanover, A. The polycomb protein RING1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol. Cell 24, 701–711 (2006). Establishes that RING1B undergoes self-ubiquitylation with the formation of multiply branched chains that do not target it for degradation but rather activate the ligase.
  CAS PubMed Google Scholar
• Kim, H. T., Kim, K. P., Uchiki, T., Gygi, S. P. & Goldberg, A. L. S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains. EMBO J. 28, 1867–1877 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zaaroor-Regev, D. et al. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proc. Natl Acad. Sci. USA 107, 6788–6793 (2010). Demonstrates that the stability of RING1B is regulated by heterologous ligases, including the HECT domain E3 E6AP.
  CAS PubMed PubMed Central Google Scholar
• Bernassola, F., Ciechanover, A. & Melino, G. The ubiquitin proteasome system and its involvement in cell death pathways. Cell Death Differ. 17, 1–3 (2010).
  CAS PubMed Google Scholar
• Vucic, D., Dixit, V. M. & Wertz, I. E. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nature Rev. Mol. Cell Biol. 12, 439–452 (2011).
  CAS Google Scholar
• Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M. & Ashwell, J. D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874–877 (2000). Demonstrates that the activation of IAPs by steroids leads to auto-ubiquitylation and the induction of apoptosis. Provides a mechanistic description of the deleterious effect of steroids on lymphocytes.
  CAS PubMed Google Scholar
• Ditzel, M. et al. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nature Cell Biol. 5, 467–473 (2003).
  CAS PubMed Google Scholar
• Ryoo, H. D., Bergmann, A., Gonen, H., Ciechanover, A. & Steller, H. Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1. Nature Cell Biol. 4, 432–438 (2002). Establishes that one mechanism of induction of apoptosis by the small protein Reaper is via its ability to bind and induce self-ubiquitylation and subsequent degradation of D. melanogaster IAP1.
  CAS PubMed Google Scholar
• Herman-Bachinsky, Y., Ryoo, H. D., Ciechanover, A. & Gonen, H. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death Differ. 14, 861–871 (2007).
  CAS PubMed Google Scholar
• Steller, H. Regulation of apoptosis in Drosophila. Cell Death Differ. 15, 1132–1138 (2008).
  CAS PubMed Google Scholar
• Wing, J. P. et al. Drosophila Morgue is an F box/ubiquitin conjugase domain protein important for grim-reaper mediated apoptosis. Nature Cell Biol. 4, 451–456 (2002).
  CAS PubMed Google Scholar
• Fu, J., Jin, Y. & Arend, L. J. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. J. Biol. Chem. 278, 52660–52672 (2003).
  CAS PubMed Google Scholar
• Silke, J., Kratina, T., Ekert, P. G., Pakusch, M. & Vaux, D. L. Unlike Diablo/Smac, Grim promotes global ubiquitination and specific degradation of X chromosome-linked inhibitor of apoptosis (XIAP) and neither cause apoptosis. J. Biol. Chem. 279, 4313–4321 (2004).
  CAS PubMed Google Scholar
• Garrison, J. B. et al. ARTS and Siah collaborate in a pathway for XIAP degradation. Mol. Cell 41, 107–116 (2011).
  CAS PubMed Google Scholar
• Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477–513 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cuervo, A. M., Palmer, A., Rivett, A. J. & Knecht, E. Degradation of proteasomes by lysosomes in rat liver. Eur. J. Biochem. 227, 792–800 (1995).
  CAS PubMed Google Scholar
• Isasa, M. et al. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Mol. Cell 38, 733–745 (2010).
  CAS PubMed PubMed Central Google Scholar
• Panasenko, O. O. & Collart, M. A. Not4 E3 ligase contributes to proteasome assembly and functional integrity in part through Ecm29. Mol. Cell. Biol. 31, 1610–1623 (2011).
  CAS PubMed PubMed Central Google Scholar
• Holic, R. et al. Cks1 activates transcription by binding to the ubiquitylated proteasome. Mol. Cell. Biol. 30, 3894–3901 (2010).
  CAS PubMed PubMed Central Google Scholar
• Tai, H. C., Besche, H., Goldberg, A. L. & Schuman, E. M. Characterization of the brain 26S proteasome and its interacting proteins. Front. Mol. Neurosci. 3, 12 (2010). A detailed analysis of the brain proteasome and its regulation by different stimuli, such as oxidative stress and NMDA receptor activity.
  PubMed PubMed Central Google Scholar
• Peth, A., Besche, H. C. & Goldberg, A. L. Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol. Cell 36, 794–804 (2009).
  CAS PubMed PubMed Central Google Scholar
• Bech-Otschir, D. et al. Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome. Nature Struct. Mol. Biol. 16, 219–225 (2009).
  CAS Google Scholar
• Sun, X. M. et al. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell 14, 81–93 (2004). Describes the regulation of the proteasome during apoptosis.
  CAS PubMed Google Scholar
• Wang, X. H. et al. Caspase-3 cleaves specific 19S proteasome subunits in skeletal muscle stimulating proteasome activity. J. Biol. Chem. 285, 21249–21257 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wang, X., Yen, J., Kaiser, P. & Huang, L. Regulation of the 26S proteasome complex during oxidative stress. Sci. Signal. 3, ra88 (2010).
  CAS PubMed PubMed Central Google Scholar
• Medicherla, B. & Goldberg, A. L. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J. Cell Biol. 182, 663–673 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bajorek, M., Finley, D. & Glickman, M. H. Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr. Biol. 13, 1140–1144 (2003). Describes the regulation of the proteasome by starvation.
  CAS PubMed Google Scholar
• Peters, J. M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nature Rev. Mol. Cell Biol. 7, 644–656 (2006).
  CAS Google Scholar
• Manchado, E., Eguren, M. & Malumbres, M. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. Biochem. Soc. Trans. 38, 65–71 (2010).
  CAS PubMed Google Scholar
• Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol. 1, 193–199 (1999).
  CAS PubMed Google Scholar
• Sutterluty, H. et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol. 1, 207–214 (1999).
  CAS PubMed Google Scholar
• Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H. & Zhang, H. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661–664 (1999).
  CAS PubMed Google Scholar
• Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. & Pagano, M. Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase. Nature 428, 190–193 (2004). References 106 and 107 establish that S phase kinase-associated protein 2 (SKP2) is targeted for degradation by the APC/C.
  CAS PubMed Google Scholar
• Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194–198 (2004).
  CAS PubMed Google Scholar
• Yamanaka, A. et al. Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome. Mol. Biol. Cell 11, 2821–2831 (2000). Provides an example of cell cycle-dependent degradation of an E2 as a means to inactive its cognate E3.
  CAS PubMed PubMed Central Google Scholar
• Listovsky, T. et al. Mammalian Cdh1/Fzr mediates its own degradation. EMBO J. 23, 1619–1626 (2004). Establishes a role for the CDH1 component of the APC/C in its own cell cycle-dependent degradation.
  CAS PubMed PubMed Central Google Scholar
• Benmaamar, R. & Pagano, M. Involvement of the SCF complex in the control of Cdh1 degradation in S-phase. Cell Cycle 4, 1230–1232 (2005).
  CAS PubMed Google Scholar
• Hsu, J. Y., Reimann, J. D., Sorensen, C. S., Lukas, J. & Jackson, P. K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1. Nature Cell Biol. 4, 358–366 (2002).
  CAS PubMed Google Scholar
• Reimann, J. D., Gardner, B. E., Margottin-Goguet, F. & Jackson, P. K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278–3285 (2001).
  CAS PubMed PubMed Central Google Scholar
• Reimann, J. D. et al. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645–655 (2001).
  CAS PubMed Google Scholar
• Di Fiore, B. & Pines, J. Defining the role of Emi1 in the DNA replication-segregation cycle. Chromosoma 117, 333–338 (2008).
  CAS PubMed Google Scholar
• Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).
  CAS PubMed Google Scholar
• Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCFβTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813–826 (2003). References 116 and 117 establish that the APC/C pseudosubstrate and inhibitor EMI1 is targeted for degradation by SCF β-TrCP.
  CAS PubMed Google Scholar
• Moshe, Y., Boulaire, J., Pagano, M. & Hershko, A. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl Acad. Sci. USA 101, 7937–7942 (2004).
  CAS PubMed PubMed Central Google Scholar
• Hansen, D. V., Loktev, A. V., Ban, K. H. & Jackson, P. K. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC inhibitor Emi1. Mol. Biol. Cell 15, 5623–5634 (2004).
  CAS PubMed PubMed Central Google Scholar
• Xu, P. et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133–145 (2009).
  CAS PubMed PubMed Central Google Scholar
• Matsumoto, M. L. et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 39, 477–484 (2010).
  CAS PubMed Google Scholar
• Saeki, Y. et al. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J. 28, 359–371 (2009).
  CAS PubMed PubMed Central Google Scholar
• Carvalho, A. F. et al. Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J. Biol. Chem. 282, 31267–31272 (2007).
  CAS PubMed Google Scholar
• Cadwell, K. & Coscoy, L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309, 127–130 (2005).
  CAS PubMed Google Scholar
• Ishikura, S., Weissman, A. M. & Bonifacino, J. S. Serine residues in the cytosolic tail of the T-cell antigen receptor α-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J. Biol. Chem. 285, 23916–23924 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177, 613–624 (2007).
  CAS PubMed PubMed Central Google Scholar
• Williams, C., van den Berg, M., Sprenger, R. R. & Distel, B. A conserved cysteine is essential for Pex4p-dependent ubiquitination of the peroxisomal import receptor Pex5p. J. Biol. Chem. 282, 22534–22543 (2007).
  CAS PubMed Google Scholar
• Tait, S. W. et al. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 179, 1453–1466 (2007).
  CAS PubMed PubMed Central Google Scholar
• Shimizu, Y., Okuda-Shimizu, Y. & Hendershot, L. M. Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Mol. Cell 40, 917–926 (2010).
  CAS PubMed PubMed Central Google Scholar
• Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495–505 (1993).
  CAS PubMed Google Scholar
• Nuber, U., Schwarz, S. E. & Scheffner, M. The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur. J. Biochem. 254, 643–649 (1998).
  CAS PubMed Google Scholar
• Hassink, G. et al. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem. J. 388, 647–655 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wang, L. et al. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II. Hepatology 48, 1558–1569 (2008).
  CAS PubMed Google Scholar
• Zavacki, A. M. et al. The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol. Cell. Biol. 29, 5339–5347 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhou, P. & Howley, P. M. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol. Cell 2, 571–580 (1998).
  CAS PubMed Google Scholar
• Li, X., Yang, Y. & Ashwell, J. D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345–347 (2002).
  PubMed Google Scholar
• Wu, W. et al. HERC2 is an E3 ligase that targets BRCA1 for degradation. Cancer Res. 70, 6384–6392 (2010).
  CAS PubMed Google Scholar
• Kee, Y., Kim, J. M. & D'Andrea, A. D. Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev. 23, 555–560 (2009). Establishes that a critical component (FANCM) of the Fanconi anaemia ubiquitin ligase is targeted for degradation by SCF β-TrCP as a way of inactivating the E3 during mitosis and preventing chromosomal abnormalities.
  CAS PubMed PubMed Central Google Scholar
• Lilley, C. E. et al. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J. 29, 943–955 (2010). Provides an example of how a virally-encoded E3 targets critical RING finger E3s involved in the DNA damage response for degradation.
  CAS PubMed PubMed Central Google Scholar
• Nathan, J. A. et al. The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic 9, 1130–1145 (2008).
  CAS PubMed PubMed Central Google Scholar
• Wada, K. & Kamitani, T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 339, 415–421 (2006).
  CAS PubMed Google Scholar
• Wada, K., Niida, M., Tanaka, M. & Kamitani, T. Ro52-mediated monoubiquitination of IKKβ down-regulates NF-κB signalling. J. Biochem. 146, 821–832 (2009).
  CAS PubMed PubMed Central Google Scholar
• Shen, C. et al. Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. J. Biol. Chem. 280, 35967–35973 (2005).
  CAS PubMed Google Scholar
• Meray, R. K. & Lansbury, P. T. J. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem. 282, 10567–10575 (2007).
  CAS PubMed Google Scholar
• Todi, S. V. et al. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 28, 372–382 (2009).
  CAS PubMed PubMed Central Google Scholar
• Todi, S. V. et al. Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117. J. Biol. Chem. 285, 39303–39313 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ying, Z. et al. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum. Mol. Genet. 18, 4268–4281 (2009).
  CAS PubMed Google Scholar
• Wada, K. & Kamitani, T. UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. Biochem. Biophys. Res. Commun. 342, 253–258 (2006).
  CAS PubMed Google Scholar
• Boutell, C., Canning, M., Orr, A. & Everett, R. D. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79, 12342–12354 (2005).
  CAS PubMed PubMed Central Google Scholar
• Lee, H. J., Kim, M. S., Kim, Y. K., Oh, Y. K. & Baek, K. H. HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized. FEBS Lett. 579, 4867–4872 (2005).
  CAS PubMed Google Scholar
• Denuc, A., Bosch-Comas, A., Gonzalez-Duarte, R. & Marfany, G. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS ONE 4, e5571 (2009).
  PubMed PubMed Central Google Scholar
• Bazirgan, O. A. & Hampton, R. Y. Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo. J. Biol. Chem. 283, 12797–12810 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kostova, Z., Mariano, J., Scholz, S., Koenig, C. & Weissman, A. M. A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation. J. Cell Sci. 122, 1374–1381 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kreft, S. G. & Hochstrasser, M. An unusual transmembrane helix in the Doa10 ERAD ubiquitin ligase modulates degradation of its cognate E2. J. Biol. Chem. 286, 20163–20174 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ho, C. W., Chen, H. T. & Hwang, J. UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae. J. Biol. Chem. 286, 21826–21834 (2011).
  CAS PubMed PubMed Central Google Scholar
• Pichler, A. et al. SUMO modification of the ubiquitin-conjugating enzyme E2–25K. Nature Struct. Mol. Biol. 12, 264–269 (2005).
  CAS Google Scholar
• Duda, D. M. et al. Structural regulation of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 21, 257–264 (2011).
  CAS PubMed PubMed Central Google Scholar